66:
386:
179:
25:
568:
Buse, John B; Rosenstock, Julio; Sesti, Giorgio; Schmidt, Wolfgang E; Montanya, Eduard; Brett, Jason H; Zychma, Marcin; Blonde, Lawrence (2009). "Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)".
530:
Pratley, Richard E; Nauck, Michael; Bailey, Timothy; Montanya, Eduard; Cuddihy, Robert; Filetti, Sebastiano; Thomsen, Anne Bloch; Søndergaard, Rie Elvang; Davies, Melanie (2010). "Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with
349:
treatment. The latter is also the best known area of Janež's scientific work, as he introduced insulin pump treatment to India, Turkey, China, Slovenia, and several other countries, where he also led the effort of educating teams of diabetologists required for a continuous application of the
758:"Effect of Rosiglitazone and Metformin on Insulin Resistance in Patients Infected with Human Immunodeficiency Virus Receiving Highly Active Antiretroviral Therapy Containing Protease Inhibitor: Randomized Prospective Controlled Clinical Trial"
509:, Janež co-authored the algorithm used in insulin pump treatment, as well as tutored virtually all Slovenian diabetologists in usage of both insulin pump and glucose sensor. Janež also wrote all of the literature on subjects of functional
893:
Tomažič, Janez; Silič, Anja; Karner, Primož; Vidmar, Ludvik; Matičič, Mojca; Poljak, Mario; Ihan, Alojz; Janež, Andrej (2004). "Lipodystrophy and metabolic abnormalities in
Slovenian HIV-infected patients".
871:
Tomazic, J; Karner, P; Vidmar, L; Maticic, M; Sharma, PM; Janez, A (2005). "Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART".
516:
Janež also led the effort of forming international standards for interpretation of results obtained with glucose sensor, publishing and presenting these on several international diabetes-related symposiums.
520:
Coupled with his previous work in the field of functional insulin therapy and its pilot implementation in
Slovenia, Janež went on to introduce this approach to diabetes treatment in other countries.
715:"Decreased Androgen Levels and Improved Menstrual Pattern after Angiotensin II Receptor Antagonist Telmisartan Treatment in Four Hypertensive Patients with Polycystic Ovary Syndrome: Case Series"
513:
and insulin pump in
Slovenia, with its audiences ranging from diabetologists to patients. In 2008, he established a new unit for functional insulin therapy within the University Medical Centre.
1062:"The osmotic shock-induced glucose transport pathway in 3T3-L1 adipocytes is mediated by Gab-1 and requires Gab-1 associated phosphatidylinositol 3-kinase activity for full activation"
1241:
1193:
1236:
331:
1172:
641:
Jensterle, M; Weber, M; Pfeifer, M; Prezelj, J; Pfutzner, A; Janez, A (2008). "Assessment of insulin resistance in young women with polycystic ovary syndrome".
801:"Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome"
330:
conference, member of the advisory board for peroral antidiabetic therapy in
Servier Pharma, member for Slovenia in the Diabetes Education Study Group at
933:"Comparison of alterations in insulin signalling pathway in adipocytes from type II diabetic pregnant women and women with gestational diabetes mellitus"
1231:
394:
207:
187:
83:
74:
506:
323:
1246:
476:
298:
280:
160:
52:
680:"Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome"
38:
457:
261:
141:
713:
Jensterle, Mojca; Janez, Andrej; Vrtovec, Bojan; Meden-Vrtovec, Helena; Pfeifer, Marija; Prezelj, Janez; Kocjan, Tomaz (2007).
429:
327:
233:
113:
90:
436:
240:
120:
608:"Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome"
1168:
842:
Mlinar, B; Marc, J; Janez, A; Pfeifer, M (2007). "Molecular mechanisms of insulin resistance and associated diseases".
1097:"Insulin-Mediated Cellular Insulin Resistance Decreases Osmotic Shock-Induced Glucose Transport in 3T3-L1 Adipocytes"
1144:
443:
410:
362:
MS, 1998, School of
Medicine, University of Ljubljana with thesis "Effects of chromium on blood pressure in humans"
247:
211:
203:
127:
1039:
Ravnik-Oblak, M; Janez, A; Kocijanicic, A (2001). "Insulinoma induced hypoglycemia in a type 2 diabetic patient".
799:
Steiner, Charles A.; Janez, Andrej; Jensterle, Mojca; Reisinger, Katrin; Forst, Thomas; Pfützner, Andreas (2007).
334:, and member of the European advisory board for continuous glucose monitoring system in development for Lifescan.
756:
Silič, Anja; Janež, Andrej; Tomažič, Janez; Karner, Primož; Vidmar, Ludvik; Sharma, Prem; Matičič, Mojca (2007).
399:
192:
425:
371:
Post doctoral, 2005, Joslin
Diabetes Clinic, Boston, study on insulin pump therapy in type 1 diabetic patients
229:
109:
403:
196:
79:
1226:
338:
1006:"Thiazolidinedione Treatment Prevents Free Fatty Acid-Induced Insulin Resistance in Male Wistar Rats"
44:
919:
666:
606:
Jensterle, M.; Sebestjen, M.; Janez, A.; Prezelj, J.; Kocjan, T.; Keber, I.; Pfeifer, M. (2008).
594:
556:
326:, Assistant Professor for Internal Medicine at the Medical University Ljubljana, Chairman of the
450:
254:
134:
1187:
1118:
1083:
1048:
1027:
992:
954:
911:
881:
859:
830:
787:
744:
701:
658:
629:
586:
548:
1108:
1073:
1017:
982:
944:
903:
851:
820:
812:
777:
769:
734:
726:
691:
650:
619:
578:
540:
365:
PhD, 2000, Diabetology School of
Medicine, University of California, San Diego, with thesis
342:
510:
494:
218:
98:
314:
is a
Slovenian diabetologist and diabetes researcher. Janež is the Head of Department of
825:
800:
782:
757:
739:
714:
582:
544:
1220:
498:
315:
1169:
http://cobiss6.izum.si/scripts/cobiss?ukaz=CLNG&lani=en&id=1224301685270796#
923:
670:
598:
931:
Tomazic, M.; Janez, A.; Sketelj, A.; Kocijancic, A.; Eckel, J.; Sharma, P. (2002).
560:
490:
346:
678:
Jensterle, M.; Janez, A.; Mlinar, B.; Marc, J.; Prezelj, J.; Pfeifer, M. (2008).
1022:
1005:
93:. Contentious material about living persons that is unsourced or poorly sourced
65:
987:
970:
816:
654:
413:. Contentious material about living people that is unsourced or poorly sourced
949:
932:
907:
855:
1113:
1096:
1122:
1087:
1078:
1061:
1052:
1031:
996:
958:
915:
885:
863:
834:
791:
773:
748:
730:
705:
662:
633:
590:
552:
502:
319:
1212:
3rd
International Conference on Advances in Diabetes and Insulin Therapy
1148:
696:
679:
624:
607:
971:"Female Rats Do Not Exhibit Free Fatty Acid-Induced Insulin Resistance"
531:
metformin: a 26-week, randomised, parallel-group, open-label trial".
367:
Mechanism of glucose transport in insulin resistant 3T3-L1 adipocytes
497:
in
Slovenia. Together with his colleagues from the Department of
341:, co-edited a clinical manual on continuous subcutaneous insulin
337:
Janež authored numerous articles on diabetology and indexed by
493:
method into clinical practice of treating adult patients with
379:
217:
from the article and its talk page, especially if potentially
172:
59:
18:
1004:
Hevener, A. L.; Reichart, D.; Janez, A.; Olefsky, J. (2001).
1211:
969:
Hevener, A.; Reichart, D.; Janez, A.; Olefsky, J. (2002).
874:
Acta Dermatovenerologica Alpina, Pannonica et Adriatica
359:
MD, 1996, School of Medicine, University of Ljubljana
643:
International Journal of Gynecology & Obstetrics
489:
Upon his return from the U.S., Janež introduced the
1192:: CS1 maint: bot: original URL status unknown (
16:Slovenian diabetologist and diabetes researcher
332:European Association for the Study of Diabetes
1242:Academic staff of the University of Ljubljana
8:
1095:Janez, A.; Worrall, DS; Olefsky, JM (2000).
53:Learn how and when to remove these messages
1237:University of California, San Diego alumni
1175:. Archived from the original on 2016-08-26
805:Journal of Diabetes Science and Technology
210:about living persons that is unsourced or
1198:Search in the Slovenian Library Database]
1112:
1077:
1021:
986:
948:
824:
781:
738:
695:
623:
477:Learn how and when to remove this message
299:Learn how and when to remove this message
281:Learn how and when to remove this message
161:Learn how and when to remove this message
328:Advances in Diabetes and Insulin Therapy
1145:"ADIT 2011 Priliminary list of Faculty"
1136:
1185:
7:
507:University Medical Centre Ljubljana
324:University Medical Centre Ljubljana
14:
1173:"Osnovno iskanje :: COBISS+"
684:European Journal of Endocrinology
612:European Journal of Endocrinology
34:This article has multiple issues.
384:
177:
64:
23:
1066:Journal of Biological Chemistry
42:or discuss these issues on the
1232:University of Ljubljana alumni
1041:Wiener Klinische Wochenschrift
896:Wiener Klinische Wochenschrift
1:
583:10.1016/S0140-6736(09)60659-0
545:10.1016/S0140-6736(10)60307-8
91:secondary or tertiary sources
395:biography of a living person
188:biography of a living person
97:, especially if potentially
75:biography of a living person
1023:10.2337/diabetes.50.10.2316
505:, and Metabolic Disease at
415:must be removed immediately
215:must be removed immediately
95:must be removed immediately
1263:
988:10.2337/diabetes.51.6.1907
817:10.1177/193229680700100212
655:10.1016/j.ijgo.2008.03.017
950:10.1007/s00125-002-0791-z
908:10.1007/s00508-004-0268-9
856:10.1016/j.cca.2006.07.005
322:and Metabolic Disease at
1247:Slovenian diabetologists
1114:10.1210/endo.141.12.7801
762:Croatian Medical Journal
719:Croatian Medical Journal
1079:10.1074/jbc.M001654200
774:10.3325/cmj.2007.6.791
731:10.3325/cmj.2007.6.864
409:Please help by adding
339:Science Citation Index
202:Please help by adding
89:Please help by adding
404:references or sources
844:Clinica Chimica Acta
208:Contentious material
697:10.1530/EJE-07-0857
625:10.1530/EJE-08-0507
78:relies too much on
1060:Janez, A. (2000).
393:This section of a
539:(9724): 1447–56.
487:
486:
479:
461:
309:
308:
301:
291:
290:
283:
265:
191:needs additional
171:
170:
163:
145:
57:
1254:
1199:
1197:
1191:
1183:
1181:
1180:
1166:
1160:
1159:
1157:
1156:
1147:. Archived from
1141:
1126:
1116:
1091:
1081:
1056:
1035:
1025:
1000:
990:
965:
962:
952:
927:
902:(21–22): 755–9.
889:
867:
838:
828:
795:
785:
752:
742:
709:
699:
674:
637:
627:
602:
564:
482:
475:
471:
468:
462:
460:
419:
411:reliable sources
388:
387:
380:
343:infusion therapy
304:
297:
286:
279:
275:
272:
266:
264:
223:
204:reliable sources
181:
180:
173:
166:
159:
155:
152:
146:
144:
103:
68:
60:
49:
27:
26:
19:
1262:
1261:
1257:
1256:
1255:
1253:
1252:
1251:
1217:
1216:
1208:
1203:
1202:
1184:
1178:
1176:
1171:
1167:
1163:
1154:
1152:
1143:
1142:
1138:
1133:
1107:(12): 4657–63.
1094:
1072:(35): 26870–6.
1059:
1038:
1016:(10): 2316–22.
1003:
968:
963:
930:
892:
870:
841:
798:
755:
712:
677:
640:
605:
577:(9683): 39–47.
567:
529:
526:
511:insulin therapy
495:type 1 diabetes
483:
472:
466:
463:
420:
418:
408:
389:
385:
378:
356:
305:
294:
293:
292:
287:
276:
270:
267:
224:
222:
201:
182:
178:
167:
156:
150:
147:
104:
102:
88:
84:primary sources
69:
28:
24:
17:
12:
11:
5:
1260:
1258:
1250:
1249:
1244:
1239:
1234:
1229:
1219:
1218:
1215:
1214:
1207:
1206:External links
1204:
1201:
1200:
1161:
1135:
1134:
1132:
1129:
1128:
1127:
1092:
1057:
1036:
1001:
981:(6): 1907–12.
966:
928:
890:
868:
850:(1–2): 20–35.
839:
796:
753:
710:
690:(6): 793–801.
675:
638:
618:(4): 399–406.
603:
565:
525:
522:
485:
484:
426:"Andrej Janež"
392:
390:
383:
377:
374:
373:
372:
369:
363:
360:
355:
352:
307:
306:
289:
288:
230:"Andrej Janež"
212:poorly sourced
185:
183:
176:
169:
168:
110:"Andrej Janež"
72:
70:
63:
58:
32:
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
1259:
1248:
1245:
1243:
1240:
1238:
1235:
1233:
1230:
1228:
1227:Living people
1225:
1224:
1222:
1213:
1210:
1209:
1205:
1195:
1189:
1174:
1170:
1165:
1162:
1151:on 2010-10-18
1150:
1146:
1140:
1137:
1130:
1124:
1120:
1115:
1110:
1106:
1102:
1101:Endocrinology
1098:
1093:
1089:
1085:
1080:
1075:
1071:
1067:
1063:
1058:
1054:
1050:
1047:(9): 339–41.
1046:
1042:
1037:
1033:
1029:
1024:
1019:
1015:
1011:
1007:
1002:
998:
994:
989:
984:
980:
976:
972:
967:
960:
956:
951:
946:
942:
938:
934:
929:
925:
921:
917:
913:
909:
905:
901:
897:
891:
887:
883:
880:(3): 99–105.
879:
875:
869:
865:
861:
857:
853:
849:
845:
840:
836:
832:
827:
822:
818:
814:
810:
806:
802:
797:
793:
789:
784:
779:
775:
771:
767:
763:
759:
754:
750:
746:
741:
736:
732:
728:
725:(6): 864–70.
724:
720:
716:
711:
707:
703:
698:
693:
689:
685:
681:
676:
672:
668:
664:
660:
656:
652:
649:(2): 137–40.
648:
644:
639:
635:
631:
626:
621:
617:
613:
609:
604:
600:
596:
592:
588:
584:
580:
576:
572:
566:
562:
558:
554:
550:
546:
542:
538:
534:
528:
527:
523:
521:
518:
514:
512:
508:
504:
500:
499:Endocrinology
496:
492:
481:
478:
470:
467:February 2011
459:
456:
452:
449:
445:
442:
438:
435:
431:
428: –
427:
423:
422:Find sources:
416:
412:
406:
405:
401:
396:
391:
382:
381:
375:
370:
368:
364:
361:
358:
357:
353:
351:
348:
344:
340:
335:
333:
329:
325:
321:
317:
316:Endocrinology
313:
303:
300:
285:
282:
274:
271:February 2011
263:
260:
256:
253:
249:
246:
242:
239:
235:
232: –
231:
227:
226:Find sources:
220:
216:
213:
209:
205:
199:
198:
194:
189:
184:
175:
174:
165:
162:
154:
151:February 2011
143:
140:
136:
133:
129:
126:
122:
119:
115:
112: –
111:
107:
106:Find sources:
100:
96:
92:
86:
85:
81:
76:
71:
67:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
1177:. Retrieved
1164:
1153:. Retrieved
1149:the original
1139:
1104:
1100:
1069:
1065:
1044:
1040:
1013:
1009:
978:
974:
943:(4): 502–8.
940:
937:Diabetologia
936:
899:
895:
877:
873:
847:
843:
811:(2): 211–7.
808:
804:
768:(6): 791–9.
765:
761:
722:
718:
687:
683:
646:
642:
615:
611:
574:
570:
536:
532:
524:Publications
519:
515:
491:insulin pump
488:
473:
464:
454:
447:
440:
433:
421:
414:
397:
366:
347:insulin pump
336:
312:Andrej Janež
311:
310:
295:
277:
268:
258:
251:
244:
237:
225:
214:
197:verification
190:
157:
148:
138:
131:
124:
117:
105:
94:
77:
50:
43:
37:
36:Please help
33:
964:(Retracted)
350:technique.
101:or harmful.
1221:Categories
1179:2011-02-24
1155:2011-02-28
1131:References
571:The Lancet
533:The Lancet
437:newspapers
241:newspapers
121:newspapers
80:references
39:improve it
398:does not
354:Education
193:citations
45:talk page
1188:cite web
1123:11108280
1088:10842168
1053:11388080
1032:11574414
1010:Diabetes
997:12031980
975:Diabetes
959:12032625
924:24715784
916:15628647
886:16200335
864:16956601
835:19888409
792:18074413
749:18074422
706:18322300
671:13513083
663:18504045
634:18653546
599:25135640
591:19515413
553:20417856
503:Diabetes
320:Diabetes
219:libelous
99:libelous
826:2771474
783:2213797
740:2213810
561:3291387
451:scholar
400:include
255:scholar
135:scholar
1121:
1086:
1051:
1030:
995:
957:
922:
914:
884:
862:
833:
823:
790:
780:
747:
737:
704:
669:
661:
632:
597:
589:
559:
551:
453:
446:
439:
432:
424:
257:
250:
243:
236:
228:
137:
130:
123:
116:
108:
920:S2CID
667:S2CID
595:S2CID
557:S2CID
458:JSTOR
444:books
345:, or
262:JSTOR
248:books
186:This
142:JSTOR
128:books
73:This
1194:link
1119:PMID
1084:PMID
1049:PMID
1028:PMID
993:PMID
955:PMID
912:PMID
882:PMID
860:PMID
831:PMID
788:PMID
745:PMID
702:PMID
659:PMID
630:PMID
587:PMID
549:PMID
430:news
402:any
376:Work
234:news
195:for
114:news
1109:doi
1105:141
1074:doi
1070:275
1045:113
1018:doi
983:doi
945:doi
904:doi
900:116
852:doi
848:375
821:PMC
813:doi
778:PMC
770:doi
735:PMC
727:doi
692:doi
688:158
651:doi
647:102
620:doi
616:159
579:doi
575:374
541:doi
537:375
82:to
1223::
1190:}}
1186:{{
1117:.
1103:.
1099:.
1082:.
1068:.
1064:.
1043:.
1026:.
1014:50
1012:.
1008:.
991:.
979:51
977:.
973:.
953:.
941:45
939:.
935:.
918:.
910:.
898:.
878:14
876:.
858:.
846:.
829:.
819:.
807:.
803:.
786:.
776:.
766:48
764:.
760:.
743:.
733:.
723:48
721:.
717:.
700:.
686:.
682:.
665:.
657:.
645:.
628:.
614:.
610:.
593:.
585:.
573:.
555:.
547:.
535:.
501:,
318:,
206:.
48:.
1196:)
1182:.
1158:.
1125:.
1111::
1090:.
1076::
1055:.
1034:.
1020::
999:.
985::
961:.
947::
926:.
906::
888:.
866:.
854::
837:.
815::
809:1
794:.
772::
751:.
729::
708:.
694::
673:.
653::
636:.
622::
601:.
581::
563:.
543::
480:)
474:(
469:)
465:(
455:·
448:·
441:·
434:·
417:.
407:.
302:)
296:(
284:)
278:(
273:)
269:(
259:·
252:·
245:·
238:·
221:.
200:.
164:)
158:(
153:)
149:(
139:·
132:·
125:·
118:·
87:.
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
